Allergan Plc Stock Current Asset
Allergan Plc fundamentals help investors to digest information that contributes to Allergan Plc's financial success or failures. It also enables traders to predict the movement of Allergan Stock. The fundamental analysis module provides a way to measure Allergan Plc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Allergan Plc stock.
Allergan |
Allergan Plc Company Current Asset Analysis
Allergan Plc's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Allergan Plc Current Asset | 8.58 B |
Most of Allergan Plc's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Allergan Plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
CompetitionIn accordance with the recently published financial statements, Allergan Plc has a Current Asset of 8.58 B. This is 298.68% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The current asset for all United States stocks is 8.13% higher than that of the company.
Allergan Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Allergan Plc's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Allergan Plc could also be used in its relative valuation, which is a method of valuing Allergan Plc by comparing valuation metrics of similar companies.Allergan Plc is currently under evaluation in current asset category among related companies.
Allergan Fundamentals
| Return On Equity | -0.0913 | |||
| Return On Asset | -0.0564 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 6.84 % | |||
| Current Valuation | 81.41 B | |||
| Shares Outstanding | 328.1 M | |||
| Shares Owned By Insiders | 0.16 % | |||
| Shares Owned By Institutions | 98.25 % | |||
| Number Of Shares Shorted | 15.01 M | |||
| Price To Earning | 24.00 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 3.95 X | |||
| Revenue | 15.82 B | |||
| Gross Profit | 13.65 B | |||
| EBITDA | 7.11 B | |||
| Net Income | (9.25 B) | |||
| Cash And Equivalents | 4.56 B | |||
| Cash Per Share | 13.88 X | |||
| Total Debt | 23.08 B | |||
| Debt To Equity | 39.40 % | |||
| Current Ratio | 1.00 X | |||
| Book Value Per Share | 161.90 X | |||
| Cash Flow From Operations | 6.47 B | |||
| Short Ratio | 3.22 X | |||
| Earnings Per Share | (27.98) X | |||
| Price To Earnings To Growth | 3.66 X | |||
| Number Of Employees | 17.4 K | |||
| Beta | 1.2 | |||
| Market Capitalization | 63.66 B | |||
| Total Asset | 135.58 B | |||
| Retained Earnings | 1.02 B | |||
| Working Capital | 287.1 M | |||
| Current Asset | 8.58 B | |||
| Current Liabilities | 8.29 B | |||
| Z Score | 1.2 | |||
| Last Dividend Paid | 0.74 |
Pair Trading with Allergan Plc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allergan Plc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allergan Plc will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to UnitedHealth Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UnitedHealth Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UnitedHealth Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UnitedHealth Group Incorporated to buy it.
The correlation of UnitedHealth Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UnitedHealth Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UnitedHealth Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UnitedHealth Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Allergan Plc information on this page should be used as a complementary analysis to other Allergan Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Allergan Stock
If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |